Tonoi Takayuki, Inohana Takehiko, Sato Teruyuki, Noda Yuuki, Ikeda Miyuki, Akutsu Miku, Murata Takatsugu, Maekawa Yutaro, Tanaka Anna, Seki Rio, Ohkusu Misako, Kamei Katsuhiko, Ishiwada Naruhiko, Shiina Isamu
Department of Applied Chemistry, Faculty of Science, Tokyo University of Science, 1-3 Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan.
Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8673, Japan.
Molecules. 2019 Sep 22;24(19):3437. doi: 10.3390/molecules24193437.
A novel stereoisomer of eushearilide, 23-demethyleushearilide, was synthesized, and the structure-activity relationships of this compound along with known eushearilide stereoisomers were investigated in order to design novel lead compounds for the treatment of fungal infections. It was discovered that all of these congeners, together with the natural product, exhibited a wide range of antimicrobial activity against not only fungi but also against bacteria, including methicillin-resistant (MRSA) and vancomycin-resistant enterococci (VRE).
合成了一种新的尤氏菌素立体异构体——23-去甲基尤氏菌素,并研究了该化合物与已知尤氏菌素立体异构体的构效关系,以便设计出用于治疗真菌感染的新型先导化合物。研究发现,所有这些同系物与天然产物一样,不仅对真菌,而且对包括耐甲氧西林金黄色葡萄球菌(MRSA)和耐万古霉素肠球菌(VRE)在内的细菌都具有广泛的抗菌活性。